TY  - JOUR 
AU  - Nieto Jiménez, Celia
AU  - Vega Moreno, Milena Amparo
AU  - Martín del Valle, Eva María
PY  - 2020
UR  - http://hdl.handle.net/10366/146737
AB  - [EN]HER2 overexpression, which occurs in a fifth of diagnosed breast cancers as well as in
other types of solid tumors, has been traditionally linked to greater aggressiveness. Nevertheless,
the clinical introduction of trastuzumab has helped to...
LA  - eng
PB  - MDPI
KW  - HER2 overexpression
KW  - Trastuzumab
KW  - Targeted nanoparticles
KW  - Targeted liposomes
KW  - Antibody-drug conjugates
KW  - Conjugation
KW  - Drug Combinations
KW  - Breast Diseases
KW  - Nanomedicine
KW  - Antibodies, Monoclonal
TI  - Trastuzumab: More than a Guide in HER2-Positive Cancer Nanomedicine
DO  - 10.3390/nano10091674
T2  - Nanomaterials
VL  - 10
M2  - 1674
ER  -